Pyrroles
- (1)
- (84)
- (1)
- (6)
- (1)
- (5)
- (2)
- (6)
- (1)
- (13)
- (1)
- (3)
- (1)
- (14)
- (46)
- (3)
- (1)
- (1)
- (1)
- (6)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (3)
- (1)
- (4)
- (1)
- (1)
- (2)
- (1)
- (7)
- (1)
- (1)
- (7)
- (2)
- (1)
- (1)
- (1)
- (5)
- (3)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (9)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (3)
- (4)
- (1)
- (2)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (2)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (2)
- (2)
- (2)
- (2)
- (4)
- (1)
- (2)
- (1)
- (4)
- (1)
- (7)
- (1)
- (12)
- (4)
- (6)
- (1)
- (2)
- (1)
- (4)
- (10)
- (4)
- (58)
- (17)
- (10)
- (2)
- (1)
- (36)
- (1)
- (2)
- (9)
- (2)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (2)
- (1)
- (1)
Filtered Search Results
Medchemexpress LLC Jnj-42226314 | 1252765-13-1 | MFCD32671350 | 99.4% | C26H24FN5O2S | 10MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
JNJ-42226314 is a selective, reversible, non-covalent monoacylglycerol lipase (MAGL) inhibitor supplied for laboratory research. It is used in biochemical and cellular studies to investigate MAGL function and endocannabinoid signaling and is provided as a high-purity material suitable for assay development and mechanistic work.
- Selective, reversible non-covalent MAGL inhibitor.
- High purity (99.4%).
- Suitable for biochemical and cellular assays.
- Provided in small research quantities (10 mg).
- Soluble in DMSO for assay preparation.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Atorvastatin hemicalcium salt | 134523-03-8 | 99.9% | 577.67 | 200 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Atorvastatin hemicalcium salt (CI-981) is an orally active 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, with blood-brain barrier permeability. It has the ability to effectively decrease blood lipids. This compound inhibits human SV-SMC proliferation and invasion with IC50s of 0.39 μM and 2.39 μM, respectively.
- Orally active 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor.
- Possesses blood-brain barrier permeability.
- Effectively decreases blood lipids.
- Inhibits human SV-SMC proliferation and invasion.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC ATORVASTATIN 3-DEOXY 50 mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
ATORVASTATIN 3-DEOXY 50MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Atorvastatin hemicalcium | 134523-03-8 | 99.94% | 577.67 | 1 ML
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Atorvastatin hemicalcium salt (CI-981) is an orally active 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor. It is capable of penetrating the blood-brain barrier and effectively reduces blood lipids. This compound inhibits human SV-SMC proliferation and invasion, and decreases apoptosis of myocardial cells by down-regulating specific proteins. It also activates endoplasmic reticulum (ER) stress in response to heart failure and angiotensin II (Ang II) stimulation. This product is for research use only.
- Orally active HMG-CoA reductase inhibitor
- Penetrates the blood-brain barrier
- Effectively reduces blood lipids
- Inhibits human SV-SMC proliferation and invasion
- Decreases myocardial cell apoptosis
- Activates endoplasmic reticulum (ER) stress response
- Reduces ER stress signaling proteins
- Inhibits proinflammatory cytokines
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC ADH-503 50 mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
ADH-503 50MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC JNJ-63576253 5 mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
JNJ-63576253 5MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Bazedoxifene | 198481-32-2 | 99.1% | C30H34N2O3 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Bazedoxifene is an oral, BBB-penetrant nonsteroidal selective estrogen receptor modulator (SERM). It is useful for osteoporosis research and inhibits IL-6/GP130 protein-protein interactions, making it suitable for pancreatic cancer research.
- Oral, BBB-penetrant nonsteroidal selective estrogen receptor modulator
- Useful in osteoporosis research
- Inhibits IL-6/GP130 protein-protein interactions
- Can be used for pancreatic cancer research
- IC50s of 23 nM for ERα and 99 nM for ERβ
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 941714-57-4 | 3-Bromo-1H-pyrrole-2-carboxylic acid methyl ester | Combi-Blocks, Inc. | MFCD23106341 | 204.023 | C6H6BrNO2 | 97.000 | COC(=O)c1[nH]ccc1Br | 100g | 837464755
3-Bromo-1H-pyrrole-2-carboxylic acid methyl ester | Combi-Blocks, Inc. | 941714-57-4 | MFCD23106341 | 204.023 | C6H6BrNO2 | 97.000 | COC(=O)c1[nH]ccc1Br | 100g | 837464755
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 625-82-1 | 2,4-Dimethyl-1H-pyrrole | ChemScene | MFCD00192088 | 95.145 | C6H9N | 95.000 | Cc1c[nH]c(C)c1 | 25g | 536855500
2,4-Dimethyl-1H-pyrrole | ChemScene | 625-82-1 | MFCD00192088 | 95.145 | C6H9N | 95.000 | Cc1c[nH]c(C)c1 | 25g | 536855500
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 941714-57-4 | Methyl 3-Bromopyrrole-2-carboxylate | Accela ChemBio | MFCD23106341 | 204.023 | C6H6BrNO2 | 95.000 | COC(=O)c1[nH]ccc1Br | 1g | 226675259
Methyl 3-Bromopyrrole-2-carboxylate | Accela ChemBio | 941714-57-4 | MFCD23106341 | 204.023 | C6H6BrNO2 | 95.000 | COC(=O)c1[nH]ccc1Br | 1g | 226675259
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 341031-54-7 | Sunitinib malate | Chemodex Ltd. | MFCD08282795 | 532.569 | C26H33FN4O7 | 98.000 | O[C@@H](CC(O)=O)C(O)=O.CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C | 1g | 887266109
Sunitinib malate | Chemodex Ltd. | 341031-54-7 | MFCD08282795 | 532.569 | C26H33FN4O7 | 98.000 | O[C@@H](CC(O)=O)C(O)=O.CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C2/C(=O)Nc3ccc(F)cc23)c1C | 1g | 887266109
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Sunitinib impurity 28 | 1186651-51-3 | 98.5% | 299.31 | 25 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Sunitinib impurity 28 is an impurity of Sunitinib. It is for research use only and not sold to patients. The appearance is a solid.
- Impurity of Sunitinib
- Appearance is a solid
- For research use only
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC JNJ-18038683 | 851376-05-1 | 98.3% | 529.97 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
JNJ-18038683 is a 5-Hydroxytryptamine Type 7 (5-HT7) receptor antagonist.
- High affinity for rat and human 5-HT7 receptors.
- Suitable for research use only.
- Suppresses REM sleep in vivo.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
eMolecules 1956327-20-0 | 6-CHLORO-2-METHYL-1H-PYRROLO[3,2-C]PYRIDINE | AstaTech | MFCD29922429 | 166.610 | C8H7ClN2 | 95.000 | Cc1cc2cnc(Cl)cc2[nH]1 | 1g | 449784994
6-CHLORO-2-METHYL-1H-PYRROLO[3,2-C]PYRIDINE | AstaTech | 1956327-20-0 | MFCD29922429 | 166.610 | C8H7ClN2 | 95.000 | Cc1cc2cnc(Cl)cc2[nH]1 | 1g | 449784994
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Atorvastatin hemicalcium trihydrate | 344920-08-7 | 99.70% | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Atorvastatin hemicalcium trihydrate is an orally active HMG-CoA reductase inhibitor that effectively decreases blood lipids. It inhibits human SV-SMC proliferation and invasion. This compound is known to reduce apoptosis of myocardial cells and activate endoplasmic reticulum stress response, making it suitable for various research applications.
- Orally active HMG-CoA reductase inhibitor
- Effectively decreases blood lipids
- Inhibits human SV-SMC proliferation and invasion
- Reduces apoptosis of myocardial cells
- Activates endoplasmic reticulum stress response
- Inhibits proinflammatory cytokines
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More